Rezolute's rare disease drug fails main goal in late-stage trial
11/12/2025 12:04
Dec 11 (Reuters) - Rezolute RZLT.O said on Thursday its experimental drug for a rare condition that causes dangerously low blood sugar failed to meet the main goal in a late-stage study. (Reporting by Kamal Choudhury in Bengaluru; Editing by Sriraj Kalluvila) ((Kamal.Choudhury@thomsonreuters.com;))